-
Mashup Score: 1Therapeutic Heparin May Benefit Moderately Ill, Hospitalized Patients With COVID-19 - ASH Clinical News - 2 year(s) ago
Therapeutic Heparin May Benefit Moderately Ill, Hospitalized Patients With COVID-19 – COVID-19 News, Literature Scan, News – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Hanny Al-Samkari: Mitapivat for Patients With Pyruvate Kinase Deficiency - ASH Clinical News - 2 year(s) ago
Hanny Al-Samkari: Mitapivat for Patients With Pyruvate Kinase Deficiency – ASH Annual Meeting, Exclusive Videos, Meeting Coverage, Multimedia – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Treatment with mitapivat improved hemoglobin and reduced transfusion burden in patients with pyruvate kinase deficiency, and these responses were sustained over time. @HannyAlSamkari shared findings from a long-term extension study at #ASH21 https://t.co/Wm2gJ8hx9C
-
-
Mashup Score: 1
Classical Hematology: A Specialty in Decline? – Feature Articles, Spotlight – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
Interesting article in @ASHClinicalNews about the workforce shortage for non-malignant/classical hematology. @ASH_hematology will fund 10 fellowship programs next year to create hematology-focused training tracks, which will help train 50 MDs by 2030. /1 https://t.co/cpFzSnfqeh
-
-
Mashup Score: 0You Must Be Present to Win - ASH Clinical News - 2 year(s) ago
You Must Be Present to Win – Advanced Practice Voices, Viewpoints – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Maintaining visibility in collaborative groups, professional organizations, and the workplace is crucial for advanced practitioners. @KurtinSandra invited Amy Pierre, RN, MSN, ANP-BC, and @DrDonaldHarvey to speak about their experiences https://t.co/GpGIyOdVTA
-
-
Mashup Score: 0Navigating Porphyria Testing Algorithms - ASH Clinical News - 2 year(s) ago
Navigating Porphyria Testing Algorithms – Demystifying the Lab, Red Blood Cell & Iron Disorders, Spotlight – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
Demystifying the Lab: @ASHClinicalNews spoke with experts about the laboratory testing used to diagnose individuals with #porphyria https://t.co/aS55UhuWfE
-
-
Mashup Score: 0
Guy Young: Fitusiran for Hemophilia A and B With Inhibitors – ASH Annual Meeting, Bleeding Disorders, Exclusive Videos, Meeting Coverage, Multimedia – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
VIDEO: Prophylactic fitusiran significantly reduced annualized bleeding rates among patients with #hemophilia A or B with inhibitors, translating to meaningful improvement in health-related QoL, according to research presented by @GuyYoungMD at #ASH21 https://t.co/57A88JEwtJ
-
-
Mashup Score: 1A Piggy pASHion - ASH Clinical News - 2 year(s) ago
A Piggy pASHion – PASHions, Spotlight – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
A Piggy pASHion: Palliative medicine physician and small residential zoo owner @kdmd88 talks about her love of animals, including a therapy pig named Zumi who delivers comfort and potbelly laughs to patients and providers https://t.co/ectQMn8kuZ
-
-
Mashup Score: 1Matthew Heeney: Crizanlizumab for Adolescents With Sickle Cell Disease - ASH Clinical News - 2 year(s) ago
Matthew Heeney: Crizanlizumab for Adolescents With Sickle Cell Disease – ASH Annual Meeting, Exclusive Videos, Meeting Coverage, Multimedia – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
VIDEO: At #ASH21, @DrHeeney discussed safety and efficacy results from the phase II SOLACE-kids trial evaluating crizanlizumab for the reduction of vaso-occlusive crises in patients aged 12 to 18 with #SickleCell disease #SCD https://t.co/aSc4Gof2Dw
-
-
Mashup Score: 0Access to Transfusions Plays “Crucial” Role in Hospice Decision-Making - ASH Clinical News - 2 year(s) ago
Access to Transfusions Plays “Crucial” Role in Hospice Decision-Making – ASH Annual Meeting, On Location – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
Blood transfusion services are considered the most important hospice-related services for patients with hematologic malignancies who are considering hospice care, according to findings from a survey study presented at #ASH21 by @OdejideOreofe https://t.co/5wAXtPoZeF
-
-
Mashup Score: 5Hind Bouzid: Is Clonal Hematopoiesis Associated With Reduced Risk of Alzheimer’s Disease? - ASH Clinical News - 2 year(s) ago
Hind Bouzid: Is Clonal Hematopoiesis Associated With Reduced Risk of Alzheimer’s Disease? – ASH Annual Meeting, Exclusive Videos, Meeting Coverage, Multimedia – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
VIDEO: Hind Bouzid, PhD, discusses recent findings of an association between clonal hematopoiesis of indeterminate potential and Alzheimer’s Disease, as well as future directions for this research #ASH21 https://t.co/3AxLQWHQ5l
-
The use of therapeutic heparin in hospitalized patients with moderately severe COVID-19 and increased D-dimer was associated with lower odds of death at 28 days https://t.co/dsnYsVFRtp